Randomized Study of Celecoxib and EKB-569, as Monotherapy or in Combination, For Prevention of Oral Cancer in Patients With Aneuploid Oral Leukoplakia
Phase of Trial: Phase III
Latest Information Update: 12 Aug 2005
At a glance
- Drugs Celecoxib (Primary) ; Pelitinib (Primary)
- Indications Orofacial cancer
- Focus Therapeutic Use
- 12 Aug 2005 New trial record.